会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 81. 发明申请
    • Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors
    • 可用作趋化因子受体抑制剂的哌啶基哌嗪衍生物
    • US20060223821A1
    • 2006-10-05
    • US11358520
    • 2006-02-21
    • Tze-Ming ChanKathleen CoxWenqing FengMichael MillerDaniel WestonStuart McCombie
    • Tze-Ming ChanKathleen CoxWenqing FengMichael MillerDaniel WestonStuart McCombie
    • A61K31/496C07D403/14
    • C07D211/96C07D401/06C07D401/14
    • In its many embodiments, the present invention provides a novel class of compounds of structural formula IA or IB where R1-R8 are as disclosed herein as inhibitors of the CCR5 receptors, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with CCR5 using such compounds or pharmaceutical compositions. The invention also relates to the use of a combination of a compound of this invention and one or more antiviral or other agents useful in the treatment of Human Immunodeficiency Virus (HIV). The invention further relates to the use of a compound of this invention, alone or in combination with another agent, in the treatment of solid organ transplant rejection, graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis.
    • 在其许多实施方案中,本发明提供了一类新颖结构式IA或IB的化合物,其中R 1至R 8如本文所公开的CCR5受体的抑制剂 制备这些化合物的方法,含有一种或多种这样的化合物的药物组合物,制备包含一种或多种这类化合物的药物制剂的方法,以及使用这种化合物治疗,预防,抑制或改善与CCR5相关的一种或多种疾病的方法 或药物组合物。 本发明还涉及本发明化合物与一种或多种可用于治疗人类免疫缺陷病毒(HIV)的抗病毒剂或其它药剂的组合的用途。 本发明还涉及本发明化合物单独或与另一种药剂组合用于治疗实体器官移植排斥,移植物抗宿主病,关节炎,类风湿性关节炎,炎症性肠病,特应性皮炎,牛皮癣 ,哮喘,过敏或多发性硬化。
    • 85. 发明授权
    • Hybrid Hall vector magnetometer
    • 混合霍尔矢量磁强计
    • US07064542B2
    • 2006-06-20
    • US11172663
    • 2005-07-01
    • Mark B. JohnsonMichael MillerBrian Bennett
    • Mark B. JohnsonMichael MillerBrian Bennett
    • G01R33/07
    • G01R33/07Y10S977/853Y10S977/865
    • A modified hybrid Hall effect device is provided which is the combination of a conventional Hall effect device and a second Hall effect device having a Hall plate coupled to a ferromagnetic layer. The hybrid Hall effect device can be used to determine the independent magnetic field vector components comprising a vector magnetic field, such as for determining the x and the z components of a magnetic field, or for measuring the total magnitude of a vector magnetic field of any orientation. The modified Hall Effect device can be adapted for use as a magnetic field sensor for the detection of macroscopic objects that have associated magnetic fields, or for microscopic objects that have been tagged by microscopic magnetic particles. In one specific form, a plurality of hybrid Hall devices are electrically connected together to form an array in which a plurality of rows of hybrid Hall devices are electrically coupled to each other along a current axis, and the array is used for the detection of microscopic objects.
    • 提供了一种改进的混合霍尔效应装置,它是常规霍尔效应装置和具有耦合到铁磁层的霍尔板的第二霍尔效应装置的组合。 可以使用混合霍尔效应装置来确定包括矢量磁场的独立磁场矢量分量,例如用于确定磁场的x和z分量,或用于测量任意的矢量磁场的总大小 方向。 修改的霍尔效应装置可以适用于用于检测具有相关磁场的宏观物体的磁场传感器,或用于由微观磁性颗粒标记的微观物体。 在一个具体形式中,多个混合霍尔器件电连接在一起以形成阵列,其中多行混合霍尔器件沿着电流轴彼此电耦合,并且该阵列用于微观检测 对象
    • 89. 发明申请
    • Bipiperidinyl derivatives useful as inhibitors of chemokine receptors
    • 可用作趋化因子受体抑制剂的二哌啶基衍生物
    • US20060025441A1
    • 2006-02-02
    • US10979075
    • 2004-11-01
    • Michael MillerJack Scott
    • Michael MillerJack Scott
    • A61K31/4545C07D401/04
    • C07D413/14C07D401/14
    • In its many embodiments, the present invention provides a novel class of bipiperidinyl compounds as inhibitors of the CCR5 receptors, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with CCR5 using such compounds or pharmaceutical compositions. The invention also relates to the use of a combination of a compound of this invention and one or more antiviral or other agents useful in the treatment of Human Immunodeficiency Virus (HIV). The invention further relates to the use of a compound of this invention, alone or in combination with another agent, in the treatment of solid organ transplant rejection, graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis.
    • 在其许多实施方案中,本发明提供了作为CCR5受体的抑制剂的新类型的联哌啶化合物,制备这些化合物的方法,含有一种或多种这样的化合物的药物组合物,制备包含一种或多种这样的化合物的药物制剂的方法,以及 使用这些化合物或药物组合物治疗,预防,抑制或改善与CCR5相关的一种或多种疾病的方法。 本发明还涉及本发明化合物与一种或多种可用于治疗人类免疫缺陷病毒(HIV)的抗病毒剂或其它药剂的组合的用途。 本发明还涉及本发明化合物单独或与另一种药剂组合用于治疗实体器官移植排斥,移植物抗宿主病,关节炎,类风湿性关节炎,炎症性肠病,特应性皮炎,牛皮癣 ,哮喘,过敏或多发性硬化。
    • 90. 发明申请
    • Color display device with enhanced pixel pattern
    • 具有增强像素图案的彩色显示设备
    • US20050270444A1
    • 2005-12-08
    • US10859314
    • 2004-06-02
    • Michael MillerMichael MurdochPaul KaneAndrew ArnoldSerguei Endrikhovski
    • Michael MillerMichael MurdochPaul KaneAndrew ArnoldSerguei Endrikhovski
    • G09G3/20G09G3/32G09G3/36G09G5/02G02F1/1335
    • G09G3/3216G09G3/20G09G3/3225G09G3/3607G09G5/02G09G2300/0452G09G2320/02
    • A color display device, comprising: an array of subpixels of at least four different colors, including at least two relatively higher luminous color subpixels and at least two relatively lower luminous color subpixels, wherein the subpixels are arranged into groups forming at least two distinct types of pixels, each pixel type including the two relatively higher luminous color subpixels and at least one of the two relatively lower luminous color subpixels, and wherein the pixel types are arranged in a pattern such that the relative locations of the two relatively higher luminous color subpixels in each pixel is repeated in adjacent pixels, and the relative location of at least one of the two relatively lower luminance color subpixels is not repeated in at least one adjacent pixel. Various embodiments of the invention enable color display devices with improved image display quality, with both the appearance of jagged lines and the appearance of banding reduced simultaneously.
    • 一种彩色显示装置,包括:至少四种不同颜色的子像素阵列,包括至少两个相对较高的发光子像素和至少两个相对较低的发光颜色子像素,其中子像素被排列成形成至少两种不同类型的组 的像素,每个像素类型包括两个相对较高的发光颜色子像素和两个相对较低的发光颜色子像素中的至少一个,并且其中像素类型被布置成使得两个相对较高的发光颜色子像素的相对位置 在相邻像素中重复每个像素,并且在至少一个相邻像素中不重复两个相对较低亮度的彩色子像素中的至少一个的相对位置。 本发明的各种实施例使得具有改善的图像显示质量的彩色显示设备能够同时缩短锯齿状线条的外观和条纹的外观。